Pfizer CEO starts book tour
Pfizer CEO Hank McKinnell kicked off a tour in support of his new book "A Call to Action: Taking Back Healthcare for Future Generations" (McGrawHill, $27.95) May 17 at the National Press Club in Washington, D.C.. Among other events, the tour is expected to include appearances on "Charlie Rose," "The McLaughlin Group," C-Span and "The Today Show." In the book, McKinnell offers a number of steps government, industry, employers and payors can take to reform the U.S. healthcare system....
You may also be interested in...
Pharmaceutical pricing decisions are based on "anticipated income" rather than achieving a return on R&D costs, Pfizer CEO Hank McKinnell writes in his recently published book A Call To Action: Taking Back Healthcare for Future Generations
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.